Evidence map›Paper›PMID 37334727›Full record

ArticleThe Kaohsiung journal of medical sciences2023

Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming.

Cheng Tang, Hui Zhang, Wen-Sheng Deng, Ling-Qiang Xiong, Li-Qiang Zhou

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Role of ENO1 and its targeted therapy in tumors.Journal of translational medicine · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cheng TangDepartment of General Surgery, The first affiliated hospital of Nanchang University, Nanchang, Jiangxi Province, China.ORCID https://orcid.org/0000-0001-9776-4821
Hui ZhangDepartment of General Surgery, The first affiliated hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Wen-Sheng DengDepartment of General Surgery, The first affiliated hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Ling-Qiang XiongDepartment of General Surgery, The first affiliated hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Li-Qiang ZhouDepartment of General Surgery, The first affiliated hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs), a rare subset of tumor cells, have been recognized as promotive role on tumor initiation and propagation. Among, aerobic glycolysis, widely clarified in multiple tumor cells, is the key for maintaining cancer stemness. Regrettably, it is largely unknown about the connection of cellular metabolic reprogramming and stemness in gastric carcinoma (GC). Two GC parental cells lines PAMC-82 and SNU-16 and their spheroids were obtained to determine the expression status of POU1F1 using quantitative real-time PCR (qRT-PCR) and western blotting analysis, respectively. Gain or loss-of-function assay was employed to assess its biological effects. Sphere formation and transwell assays were performed to evaluate the stem cell-like traits, including self-renewal capacity, migration and invasion. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays were conducted for determining the binding relationship of POU1F1 on ENO1 promoter region. Herein, aberrantly upregulated POU1F1 was observed in spheroids, compared with the parental PAMC-82 and SNU-16 cells, which promoted stem cell-like traits, as representing increasing sphere formation, enhanced cell migration and invasion. Additionally, POU1F1 expression was positively with glycolytic signaling, as displaying increasing glucose consumption, lactic acid production, and extracellular acid ratio (ECAR). Furthermore, POU1F1 was identified to be a transcriptional activator of ENO1, of which overexpression remarkably abolished POU1F1 knockdown-mediated blocking effects. Taken together, we draw a conclusion that POU1F1 facilitated the stem cell-like properties of GC cells through transcriptionally augmenting ENO1 to enhance glycolysis.

Indexed as

CarcinomaStomach NeoplasmsBiomarkers, TumorCell Line, TumorCell ProliferationDNA-Binding ProteinsGene Expression Regulation, NeoplasticGlycolysisHumansNeoplastic Stem CellsPhosphopyruvate HydrataseTranscription Factor Pit-1Transcription FactorsTumor Suppressor ProteinsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanPhosphopyruvate HydratasePOU1F1 protein, humanTranscription Factor Pit-1Transcription FactorsTumor Suppressor ProteinsENO1gastric carcinomaglycolysisPOU1F1stemness

Identifiers

PMID37334727
PMCPMC11895930
OpenAlexW4381158317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.